Qualisure News IN THE NEWS PRESS REALEASES EVENTS AND CONFERENCES Search Search Unique Thyroid Cancer Tests: New Hope Unveiled Read More > Precision Oncology Test Thyroid GuidePx® Now Available From Qualisure Diagnostics Read More > Qualisure submits an international PCT patent application for the molecular subclassification of papillary thyroid cancer Read More > Qualisure is awarded a $100,000 Voucher grant from Alberta Innovates Read More > University of Calgary invests $150,000 in Qualisure through the UCeed Health Fund Read More > Dr. Oliver Bathe (CEO) and collaborators are awarded the Jennifer Gardiner Award in Surgical Oncology Research Read More > Qualisure announces partnership with Orlando, Florida-based Protean BioDiagnostics Inc. Read More > Qualisure partners with Calgary, Alberta-based OncoHelix Inc. Read More > Qualisure is awarded a $295,000 AICE-Validate grant from Alberta Innovates Read More > Qualisure Diagnostics Inc. acquires an array of intellectual property from Innovate Calgary Read More > READ MORE Unique Thyroid Cancer Tests: New Hope Unveiled Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023] Surgical Approaches to Thyroid Cancer
A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]